Details of the Drug

General Information of Drug (ID: DMKH7QV)

Drug Name

TBX-3400

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03385486) Study of TBX-3400 in Patients With Stage III and IV Melanoma Resistant or Refractory to Immune Checkpoint Inhibitors. U.S. National Institutes of Health.